ArticleOncotarget2017

Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts.

Ines Lohse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.